Sunday tips round-up: Genus, IG Group, Titan Europe...

12th Sep 2010 10:48

Genus provides animals which have better genes compared with current livestock in terms of yield, health and hardiness. It produces the sperm (in the case of bulls) or animals (in the case of pigs) that provides these traits. Animals with better genes produce more meat, live longer and are cheaper in terms of vet bills. The shares are trading on a June 2011 earnings multiple of 19.3 times, falling to 16.8 in 2012. The yield is 1.7%. A buy based the long-term bull market in food production says the Telegraph.Spread bet firm IG benefits from market volatility, as trade volumes increase, and it said that volumes were subdued in the second half of its third quarter. Trading on a May 2011 earnings multiple of 14.8, falling to 13.2 in 2012, the Telegraph is comfortable with a hold rating on the shares. Comparisons in the next few quarters are going to get tougher and the company is itself cautious on prospects.Sinclair Pharma's products include acne cream, cures for athlete's foot, eczema relief and burn products, as well as a host of other treatments for skin and mouth problems. Over the next few years, the company should deliver some exciting growth, particularly if his ambitions are fulfilled. The company is relatively small and there are some risks attached, but for those prepared to have a bit of a punt, the shares could prove highly rewarding. Buy says the Mail on Sunday.Titan Europe makes big wheels and its shares have been on an extraordinary ride in recent months. Full-year results are expected to show sales up by at least 30% to more than £345m and the group should deliver profits of about £700,000 against a £41m loss in 2009. Next year's figures are forecast to be much stronger, with profits surging to more than £13m, but investors would do well to sell at least half their holdings and bank some profits now, suggests the Mail on Sunday.